Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroprotection in a novel mouse model of multiple sclerosis.
Episode 7 with Dr. Daniel Kantor on access to care
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
ForuMS: A Virtual Journal Club for MS Clinicians
Keystone Symposium: Dendritic Cells and Macrophages Reunited
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
46th Annual WCBR Winter Conference on Brain Research
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Firategrast: natalizumab in a pill?
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
Cerebellar cortical demyelination in the murine cuprizone model.
Genes associated with T helper 17 cell differentiation and function.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.

Pages